Utprøving av tiltak for å få nedvandrende ål levende forbi kraftverk. Årsrapport 2010, Storelva i Holt i Aust-Agder

Autor: Kroglund, Frode, Güttrup, Jim, Hegland, Peder Vaaje, Lund, Espen, Fjeld, Eirik, Grung, Merete, Haraldstad, Tormod

Externí odkaz: http://hdl.handle.net/11250/215880

Fellegi-Holt´i meetod ja deduktiivne imputeerimine andmestiku Väliskülastajad Eestis näitel

Autor: Raudsik, Joosep

Käesolev töö annab ülevaate Fellegi-Holt´i paradigmast ning erinevatest võimalustest selle lahendamiseks. Antud põhimõtet kasutatakse tihti automaatses andmete parandamises. Lähenemine seisneb vea tuvastamise probleemi lahendamises läbi jä

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1018::ba81bea968595f6c09333f6fa2c7240b
http://hdl.handle.net/10062/47569

Proteomic characterization of human LMNA-related congenital muscular dystrophy muscle cells.

Autor: Storey EC; Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, SY10 7AG, UK; The School of Pharmacy and Bioengineering, Keele University, ST5 5BG, UK., Holt I; Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, SY10 7AG, UK; The School of Pharmacy and Bioengineering, Keele University, ST5 5BG, UK., Brown S; Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, SY10 7AG, UK; The School of Pharmacy and Bioengineering, Keele University, ST5 5BG, UK., Synowsky S; BSRC Mass Spectrometry and Proteomics Facility, University of St Andrews, KY16 9ST, UK., Shirran S; BSRC Mass Spectrometry and Proteomics Facility, University of St Andrews, KY16 9ST, UK., Fuller HR; Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry, SY10 7AG, UK; The School of Pharmacy and Bioengineering, Keele University, ST5 5BG, UK. Electronic address: h.r.fuller@keele.ac.uk.

Publikováno v: Neuromuscular disorders : NMD [Neuromuscul Disord] 2024 May; Vol. 38, pp. 26-41. Date of Electronic Publication: 2024 Mar 15.

Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.

Autor: Lange B; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Brunswick, Germany. Berit.Lange@helmholtz-hzi.de.; German Center for Infection Research (DZIF), TI BBD, Brunswick, Germany. Berit.Lange@helmholtz-hzi.de., Jaeger VK; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Harries M; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Brunswick, Germany., Rücker V; Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Streeck H; Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany., Blaschke S; Emergency Department, University Medical Center Göttingen, Göttingen, Germany., Petersmann A; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Oldenburg, Oldenburg, Germany.; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Toepfner N; Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Nauck M; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine Greifswald, Greifswald, Germany., Hassenstein MJ; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Brunswick, Germany., Dreier M; Institute for Epidemiology, Social Medicine and Health Systems Research, Hannover Medical School, Hannover, Germany., von Holt I; Institute for Epidemiology, Social Medicine and Health Systems Research, Hannover Medical School, Hannover, Germany., Budde A; Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany., Bartz A; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Ortmann J; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Brunswick, Germany., Kurosinski MA; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Berner R; Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Borsche M; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany., Brandhorst G; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Oldenburg, Oldenburg, Germany., Brinkmann M; Institute for Epidemiology, Social Medicine and Health Systems Research, Hannover Medical School, Hannover, Germany., Budde K; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Deckena M; MVZ Labor Krone GbR, Bad Salzuflen, Germany., Engels G; Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Fenzlaff M; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Härtel C; Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Hovardovska O; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Brunswick, Germany., Katalinic A; Institute of Social Medicine and Epidemiology, University of Luebeck, Luebeck, Germany., Kehl K; Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany., Kohls M; Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Krüger S; Dimap, das Institut Für Markt- Und Politikforschung GmbH, Bonn, Germany., Lieb W; Institute of Epidemiology, Christian-Albrechts-University of Kiel, Kiel, Germany., Meyer-Schlinkmann KM; MVZ Labor Krone GbR, Bad Salzuflen, Germany., Pischon T; Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Biobank Technology Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Charité-Universitätsmedizin Berlin, Berlin corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Rosenkranz D; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Oldenburg, Oldenburg, Germany., Rübsamen N; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Rupp J; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany., Schäfer C; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Schattschneider M; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Schlegtendal A; University Children's Hospital, Ruhr University Bochum, Bochum, Germany., Schlinkert S; Dimap, das Institut Für Markt- Und Politikforschung GmbH, Bonn, Germany., Schmidbauer L; Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany., Schulze-Wundling K; Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany., Störk S; Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center (CHFC), and Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany., Tiemann C; MVZ Labor Krone GbR, Bad Salzuflen, Germany., Völzke H; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany., Winter T; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Klein C; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany., Liese J; Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Brinkmann F; University Children's Hospital, Ruhr University Bochum, Bochum, Germany., Ottensmeyer PF; Institute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany., Reese JP; Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.; Institute for Medical Data Science, University Hospital Würzburg, Würzburg, Germany., Heuschmann P; Institute of Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.; Institute for Medical Data Science, University Hospital Würzburg, Würzburg, Germany.; Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany., Karch A; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany. akarch@uni-muenster.de.

Publikováno v: Infection [Infection] 2024 Feb; Vol. 52 (1), pp. 139-153. Date of Electronic Publication: 2023 Aug 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.